Biogen Inc. buy Truist Financial Co.
Start price
29.04.25
/
50%
€105.40
Target price
29.04.26
€174.72
Performance (%)
57.13%
End price
30.04.26
€165.62
Summary
This prediction ended on 30.04.26 with a price of €165.62. With a performance of 57.13% the BUY prediction by Truist_Financial_Co_ was a big success. Truist_Financial_Co_ has a follow-up prediction for Biogen Inc. where he still thinks Biogen Inc. is a Buy. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 4.976% | 4.976% | 65.471% |
| iShares Core DAX® | -1,09 % | 0,20 % | 2,09 % |
| iShares Nasdaq 100 | -2,46 % | -1,79 % | 29,25 % |
| iShares Nikkei 225® | -5,37 % | -5,43 % | 54,33 % |
| iShares S&P 500 | -0,20 % | 1,77 % | 23,58 % |
Comments by Truist_Financial_Co_ for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Truist Financial Co. from $210.00 to $199.00. They now have a "buy" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten

